IL99306A - HISTORY OF THE TROCCLAMIDE ALKYLAMIDS, AGONISTIC NAME SEROTONIN A1TH5 PROCESS FOR THE PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM - Google Patents

HISTORY OF THE TROCCLAMIDE ALKYLAMIDS, AGONISTIC NAME SEROTONIN A1TH5 PROCESS FOR THE PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM

Info

Publication number
IL99306A
IL99306A IL9930691A IL9930691A IL99306A IL 99306 A IL99306 A IL 99306A IL 9930691 A IL9930691 A IL 9930691A IL 9930691 A IL9930691 A IL 9930691A IL 99306 A IL99306 A IL 99306A
Authority
IL
Israel
Prior art keywords
compound according
phenyl
represented
ppm
nmr
Prior art date
Application number
IL9930691A
Other languages
English (en)
Hebrew (he)
Other versions
IL99306A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL99306A0 publication Critical patent/IL99306A0/xx
Publication of IL99306A publication Critical patent/IL99306A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
IL9930691A 1990-08-29 1991-08-26 HISTORY OF THE TROCCLAMIDE ALKYLAMIDS, AGONISTIC NAME SEROTONIN A1TH5 PROCESS FOR THE PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM IL99306A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57471090A 1990-08-29 1990-08-29
US07/735,700 US5189179A (en) 1990-08-29 1991-07-30 Serotonin 5ht1a agonists

Publications (2)

Publication Number Publication Date
IL99306A0 IL99306A0 (en) 1992-07-15
IL99306A true IL99306A (en) 1995-03-30

Family

ID=27076473

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9930691A IL99306A (en) 1990-08-29 1991-08-26 HISTORY OF THE TROCCLAMIDE ALKYLAMIDS, AGONISTIC NAME SEROTONIN A1TH5 PROCESS FOR THE PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM

Country Status (21)

Country Link
US (3) US5189179A (fr)
EP (1) EP0478954B1 (fr)
JP (1) JPH04270264A (fr)
KR (1) KR920004345A (fr)
CN (1) CN1030766C (fr)
AT (1) ATE197040T1 (fr)
AU (1) AU641535B2 (fr)
CA (1) CA2049803A1 (fr)
DE (1) DE69132450T2 (fr)
DK (1) DK0478954T3 (fr)
ES (1) ES2153346T3 (fr)
FI (1) FI914065A (fr)
GR (1) GR3035062T3 (fr)
HU (1) HU208955B (fr)
IE (1) IE913036A1 (fr)
IL (1) IL99306A (fr)
NO (1) NO175430C (fr)
NZ (1) NZ239521A (fr)
PH (1) PH30242A (fr)
PT (1) PT98800B (fr)
TW (1) TW200457B (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189179A (en) * 1990-08-29 1993-02-23 Merrell Dow Pharmaceuticals Inc. Serotonin 5ht1a agonists
US5892112A (en) * 1990-11-21 1999-04-06 Glycomed Incorporated Process for preparing synthetic matrix metalloprotease inhibitors
USRE38506E1 (en) 1991-10-04 2004-04-20 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and methods of use thereof
US6406859B1 (en) 1992-01-08 2002-06-18 Synaptic Pharmaceutical Corporation DNA encoding a 5-HT 1F receptor and uses thereof
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
GB9304632D0 (en) * 1993-03-06 1993-04-21 Wyeth John & Brother Ltd Amide derivatives
FR2707294B1 (fr) * 1993-07-06 1995-09-29 Pf Medicament Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine.
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
US6462048B2 (en) * 1996-03-29 2002-10-08 Pfizer Inc. Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-HT1A- and/or 5-HT1D receptors
US5872145A (en) * 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
US6586458B1 (en) 1996-08-16 2003-07-01 Pozen Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
EP1068199B1 (fr) * 1998-04-08 2002-11-13 Wyeth N-aryloxyethyle-indoly-alkylamines pour le traitement de la depression
US6121307A (en) 1998-04-08 2000-09-19 American Home Products Corp. N-aryloxyethyl-indoly-alkylamines for the treatment of depression
EP1070063A1 (fr) * 1998-04-08 2001-01-24 American Home Products Corporation Derives d'amine indol-3-yl-cyclhexyle utilises dans le traitement de la depression (antagonistes du recepteur 5-ht1)
US6150533A (en) * 1998-04-08 2000-11-21 American Home Products Corp. N-aryloxyethyl-indoly-alkylamines for the treatment of depression
JP2002510675A (ja) * 1998-04-08 2002-04-09 アメリカン・ホーム・プロダクツ・コーポレイション うつ病治療用のｎ−アリールオキシエチル−インドリル−アルキルアミン（５−ｈｔ１ａ受容体活性薬）
US7588029B2 (en) * 2000-03-21 2009-09-15 Fisher & Paykel Healthcare Limited Humidified gases delivery apparatus
AU2002325712C1 (en) 2001-08-30 2008-07-31 Stem Cell Therapeutics Inc. Differentiation of neural stem cells and therapeutic use theeof
AR036401A1 (es) * 2001-09-14 2004-09-08 Stem Cell Therapeutics Inc Incremento de la cantidad de celulas madre neuronales inducido por prolactina.
AU2002325710A1 (en) * 2001-09-18 2003-04-01 Stem Cell Therapeutics Inc. Effect of growth hormone and igf-1 on neural stem cells and therapeutic application
EP1546198A1 (fr) * 2002-07-31 2005-06-29 Stem Cell Therapeutics Inc. Procede d'amelioration de la proliferation, de la differentiation et de la survie de cellules souches neurales au moyen du polypeptide d'activation d'adenylate cyclase hypophysaire (pacap)
US7332183B2 (en) * 2002-12-26 2008-02-19 Pozen Inc. Multilayer dosage forms containing NSAIDs and triptans
WO2004110492A2 (fr) * 2003-06-06 2004-12-23 Glaxo Group Limited Composition pharmaceutique
US20050080084A1 (en) * 2003-07-11 2005-04-14 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of central nervous system damage
US20070111932A1 (en) * 2003-07-31 2007-05-17 Stem Cell Therapeutics Inc. Method of enhancing and/or inducing neuronal migration using erythropoietin
CA2536340A1 (fr) * 2003-08-22 2005-03-03 Pharmacia Corporation Compositions d'un inhibiteur selectif de la cyclo-oxygenase 2 et d'un agent de modulation de la serotonine pour le traitement de la neoplasie
CN1325673C (zh) * 2003-12-30 2007-07-11 上海交通大学 利用废旧紫铜生产无氧铜的装置
CA2556266A1 (fr) * 2004-02-13 2005-08-25 Stem Cell Therapeutics Corp. Utilisation de l'hormone de luteinisation (lh) et de la gonadotropine chorionique (hcg) pour la proliferation de cellules souches neuronales et la neurogenese
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
AU2006249577A1 (en) 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
AU2006297041A1 (en) * 2005-09-27 2007-04-05 Stem Cell Therapeutics Corp. Oligodendrocyte precursor cell proliferation regulated by prolactin
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
AR058389A1 (es) 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US20070191474A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
JP2009530234A (ja) 2006-03-17 2009-08-27 ステム セル セラピューティクス コーポレイション 神経変性疾患の治療のためのｌｈまたはｈｃｇ、およびｅｐｏについての投与レジメン
JP2009537635A (ja) 2006-05-19 2009-10-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 癲癇の処置のための共同−療法
CA2729056A1 (fr) 2008-06-23 2010-01-21 Janssen Pharmaceutica Nv Forme cristalline de (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
CN111116451A (zh) * 2020-01-16 2020-05-08 宁波大学 一种多取代色胺基苯甲酰胺类化合物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2725386A (en) * 1953-02-13 1955-11-29 Fond Emanuele Paterno 2-(1, 4-benzodioxan) methyl derivatives of amino-lower fatty acid amides and preparation thereof
FR2463765A1 (fr) * 1979-08-17 1981-02-27 Clin Midy Nouveaux derives de l'indole actifs sur le systeme cardiovasculaire
US4684739A (en) * 1980-12-15 1987-08-04 Mitsubishi Chemical Industries Limited Alkylenedioxybenzene derivatives and acid addition salts thereof
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
ES2044970T3 (es) * 1986-06-26 1994-01-16 Ciba Geigy Ag Procedimiento para la obtencion de compuestos hidrogenados del acido 1-benzooxacicloalquil-piridincarboxilico.
DE3642497A1 (de) * 1986-12-12 1988-06-23 Hoechst Ag Substituierte aminopropionsaeureamide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
US4956382A (en) * 1987-02-07 1990-09-11 Pfizer Inc. Sulfonamide anti-arrhythmic agents
US5189179A (en) * 1990-08-29 1993-02-23 Merrell Dow Pharmaceuticals Inc. Serotonin 5ht1a agonists
US5120758A (en) * 1991-02-08 1992-06-09 Ciba-Geigy Corporation Certain benzodioxole, benzodioxane and benzodioxepin derivatives useful as 5-lipoxygenase inhibitors

Also Published As

Publication number Publication date
HU208955B (en) 1994-02-28
IE913036A1 (en) 1992-03-11
KR920004345A (ko) 1992-03-27
DE69132450T2 (de) 2001-05-03
DE69132450D1 (de) 2000-11-23
AU8266491A (en) 1992-03-05
EP0478954B1 (fr) 2000-10-18
DK0478954T3 (da) 2001-01-08
FI914065A0 (fi) 1991-08-28
ATE197040T1 (de) 2000-11-15
EP0478954A1 (fr) 1992-04-08
CN1030766C (zh) 1996-01-24
PH30242A (en) 1997-02-05
TW200457B (fr) 1993-02-21
CN1059717A (zh) 1992-03-25
JPH04270264A (ja) 1992-09-25
IL99306A0 (en) 1992-07-15
FI914065A (fi) 1992-03-01
NO175430C (no) 1994-10-12
PT98800B (pt) 1999-01-29
CA2049803A1 (fr) 1992-03-01
NO913384L (no) 1992-03-02
US5559143A (en) 1996-09-24
NZ239521A (en) 1993-07-27
NO913384D0 (no) 1991-08-28
ES2153346T3 (es) 2001-03-01
HUT59092A (en) 1992-04-28
US5387604A (en) 1995-02-07
NO175430B (no) 1994-07-04
GR3035062T3 (en) 2001-03-30
US5189179A (en) 1993-02-23
AU641535B2 (en) 1993-09-23
PT98800A (pt) 1992-08-31

Similar Documents

Publication Publication Date Title
EP0478954B1 (fr) Agonistes 5HT1A et 5HT1D de la sérotonine
US5464872A (en) Arylalkyl (thio) amides
JPH05186431A (ja) Ｎ−置換ヘテロ環誘導体、製法および医薬組成物
JPH0428698B2 (fr)
FR2903101A1 (fr) Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PL191876B1 (pl) Nowe kwasy sulfonyloaminokarboksylowe i sposób ich wytwarzania, środek farmaceutyczny i ich zastosowanie do wytwarzania leku
EP0406734A2 (fr) 2-(Aminoaryl)indoles et indolines, leur procédé de préparation et leur utilisation comme médicaments
JPS61249960A (ja) Ｎ―インドリルエチル―スルホン酸アミド類、その製法及び用途
BG63940B1 (bg) Бифенилсулфонамидни инхибитори на металопротеиназата на матрикса
FR2635104A1 (fr) Derives d'indolone, leur preparation et leur application en therapeutique
FR2630328A1 (fr) Derive de l'histamine, sa preparation et son application en therapeutique
IL203956A (en) Indole-2-on-2 derivatives are positioned in position 3, their preparation and use for drug preparation
KR900004385B1 (ko) 카복사미드 유도체 및 그의 제조방법
NO311257B1 (no) Indoler med brostruktur som matriksmetallproteaseinhibitorer, samt farmasöytiske preparater som omfatter dem
EP0526478B1 (fr) Derives de 3-indolyle thioacetate
NZ524404A (en) Indole derivatives and their use as medicaments
FR2680172A1 (fr) Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique.
JPH0625128A (ja) 新規なナフタレンアミドおよびナフタレンスルホンアミド化合物
EP0841330B1 (fr) Nouveaux dérivés aminométhyl hétérocycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
KR20060036091A (ko) 신규 화합물
EP0782568B1 (fr) Ethers aromatiques derives d'indoles comme "5ht1-like" ligands
BG62349B2 (bg) N-заместени производни на 3-азабицикло/3.2.0/хептан като невролептици
AU2002300093B2 (en) New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them
JP2003523343A (ja) アミノ酸化合物、ならびにｎｅｐ、ａｃｅおよびｅｃｅ阻害剤としてのその使用
CA2315703C (fr) Inhibiteur de tripeptidyl peptidase

Legal Events

Date Code Title Description
KB Patent renewed
HC Change of name of proprietor(s)
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PARMACEUTICALS, INC.